The Network Advantage: A Regulatory Perspective on Clinical Research Innovation

In this informative session, clinical trial professionals will have an opportunity to hear directly from the FDA’s David Burrow on ways industry can advance clinical trial innovation. David will discuss the Center for Drug Evaluation and Research (CDER) Center for Clinical Trial Innovation (C3TI), along with perspectives on the growing role of artificial intelligence and other technologies in trial operations. He will also share valuable opportunities for industry to give FDA important input via C3TI demonstration projects and other initiatives which help shape the global clinical research ecosystem.